{"entity":{"type":"insider","cik":"0001543425","url":"/insider/0001543425","json_url":"/insider/0001543425.json","name":"ELDRED KARY","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":14,"first":"2018-09-26","last":"2026-02-09","span_basis":"filed_date"},"name_variants":[{"name":"ELDRED KARY","source":"filing","n_filings":14,"first_seen":"2018-09-26","last_seen":"2026-02-09"}],"transactions":[{"id":5769835,"accession":"0001133416-26-000048","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-26-000048","line_url":"/filing/0001133416-26-000048#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001543425","owner_name":"ELDRED KARY","owner_display_name":"ELDRED KARY","owner_url":"/insider/0001543425","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":2.7,"price_display":"2.70","price_state":"stated","total_value":810.0,"total_display":"810.00","total_whole":"810","shares_owned_after":65682.0,"shares_owned_after_display":"65,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-06","filed_date":"2026-02-09","scope":"insider"},{"id":5024116,"accession":"0001133416-25-000074","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-25-000074","line_url":"/filing/0001133416-25-000074#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001543425","owner_name":"ELDRED KARY","owner_display_name":"ELDRED KARY","owner_url":"/insider/0001543425","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":700.0,"shares_display":"700","price_per_share":3.73,"price_display":"3.73","price_state":"stated","total_value":2611.0,"total_display":"2,611.00","total_whole":"2,611","shares_owned_after":65382.0,"shares_owned_after_display":"65,382","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-23","filed_date":"2025-12-23","scope":"insider"},{"id":4371222,"accession":"0001133416-25-000078","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-25-000078","line_url":"/filing/0001133416-25-000078#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001543425","owner_name":"ELDRED KARY","owner_display_name":"ELDRED KARY","owner_url":"/insider/0001543425","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":700.0,"shares_display":"700","price_per_share":3.73,"price_display":"3.73","price_state":"stated","total_value":2611.0,"total_display":"2,611.00","total_whole":"2,611","shares_owned_after":65382.0,"shares_owned_after_display":"65,382","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-23","filed_date":"2025-12-23","scope":"insider"},{"id":4925109,"accession":"0001133416-25-000035","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-25-000035","line_url":"/filing/0001133416-25-000035#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001543425","owner_name":"ELDRED KARY","owner_display_name":"ELDRED KARY","owner_url":"/insider/0001543425","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":2.925,"price_display":"2.92","price_state":"stated","total_value":2925.0,"total_display":"2,925.00","total_whole":"2,925","shares_owned_after":64682.0,"shares_owned_after_display":"64,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-07-21","filed_date":"2025-07-22","scope":"insider"},{"id":2466246,"accession":"0001133416-24-000064","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-24-000064","line_url":"/filing/0001133416-24-000064#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001543425","owner_name":"ELDRED KARY","owner_display_name":"ELDRED KARY","owner_url":"/insider/0001543425","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13469.0,"shares_display":"13,469","price_per_share":0.82,"price_display":"0.82","price_state":"stated","total_value":11044.58,"total_display":"11,044.58","total_whole":"11,045","shares_owned_after":63682.0,"shares_owned_after_display":"63,682","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-24","filed_date":"2024-12-26","scope":"insider"},{"id":2584081,"accession":"0001133416-24-000060","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-24-000060","line_url":"/filing/0001133416-24-000060#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001543425","owner_name":"ELDRED KARY","owner_display_name":"ELDRED KARY","owner_url":"/insider/0001543425","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":2.6,"price_display":"2.60","price_state":"stated","total_value":1300.0,"total_display":"1,300.00","total_whole":"1,300","shares_owned_after":50213.0,"shares_owned_after_display":"50,213","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-23","filed_date":"2024-10-23","scope":"insider"},{"id":9228235,"accession":"0001133416-24-000048","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-24-000048","line_url":"/filing/0001133416-24-000048#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001543425","owner_name":"ELDRED KARY","owner_display_name":"ELDRED KARY","owner_url":"/insider/0001543425","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":2.39,"price_display":"2.39","price_state":"stated","total_value":956.0,"total_display":"956.00","total_whole":"956","shares_owned_after":49713.0,"shares_owned_after_display":"49,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-22","filed_date":"2024-07-23","scope":"insider"},{"id":2980424,"accession":"0001133416-24-000046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-24-000046","line_url":"/filing/0001133416-24-000046#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001543425","owner_name":"ELDRED KARY","owner_display_name":"ELDRED KARY","owner_url":"/insider/0001543425","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":2.39,"price_display":"2.39","price_state":"stated","total_value":956.0,"total_display":"956.00","total_whole":"956","shares_owned_after":49713.0,"shares_owned_after_display":"49,713","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-07-23","scope":"insider"},{"id":2504838,"accession":"0001133416-24-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-24-000004","line_url":"/filing/0001133416-24-000004#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001543425","owner_name":"ELDRED KARY","owner_display_name":"ELDRED KARY","owner_url":"/insider/0001543425","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":1.7858,"price_display":"1.79","price_state":"stated","total_value":892.9,"total_display":"892.90","total_whole":"893","shares_owned_after":49313.0,"shares_owned_after_display":"49,313","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-16","filed_date":"2024-01-16","scope":"insider"},{"id":8731039,"accession":"0001133416-23-000065","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-23-000065","line_url":"/filing/0001133416-23-000065#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001543425","owner_name":"ELDRED KARY","owner_display_name":"ELDRED KARY","owner_url":"/insider/0001543425","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1598.0,"shares_display":"1,598","price_per_share":1.786,"price_display":"1.79","price_state":"stated","total_value":2854.028,"total_display":"2,854.03","total_whole":"2,854","shares_owned_after":48813.0,"shares_owned_after_display":"48,813","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-19","filed_date":"2023-07-20","scope":"insider"},{"id":7927606,"accession":"0001133416-23-000043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-23-000043","line_url":"/filing/0001133416-23-000043#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001543425","owner_name":"ELDRED KARY","owner_display_name":"ELDRED KARY","owner_url":"/insider/0001543425","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":1.5911,"price_display":"1.59","price_state":"stated","total_value":1591.1,"total_display":"1,591.10","total_whole":"1,591","shares_owned_after":47215.0,"shares_owned_after_display":"47,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-21","filed_date":"2023-02-21","scope":"insider"},{"id":8541128,"accession":"0001133416-23-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001133416-23-000006","line_url":"/filing/0001133416-23-000006#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001543425","owner_name":"ELDRED KARY","owner_display_name":"ELDRED KARY","owner_url":"/insider/0001543425","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1300.0,"shares_display":"1,300","price_per_share":1.11,"price_display":"1.11","price_state":"stated","total_value":1443.0,"total_display":"1,443.00","total_whole":"1,443","shares_owned_after":46215.0,"shares_owned_after_display":"46,215","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-25","filed_date":"2023-01-26","scope":"insider"},{"id":8096918,"accession":"0001179022-19-000036","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179022-19-000036","line_url":"/filing/0001179022-19-000036#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001543425","owner_name":"ELDRED KARY","owner_display_name":"ELDRED KARY","owner_url":"/insider/0001543425","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3033.0,"shares_display":"3,033","price_per_share":4.28,"price_display":"4.28","price_state":"stated","total_value":12981.24,"total_display":"12,981.24","total_whole":"12,981","shares_owned_after":44415.0,"shares_owned_after_display":"44,415","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-31","filed_date":"2019-06-03","scope":"insider"},{"id":6037014,"accession":"0001179022-18-000072","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179022-18-000072","line_url":"/filing/0001179022-18-000072#line-1","is_derivative":false,"issuer_cik":"0001133416","issuer_name":"GALECTIN THERAPEUTICS INC","issuer_ticker":"GALT","issuer_name_source":null,"issuer_url":"/issuer/0001133416","owner_cik":"0001543425","owner_name":"ELDRED KARY","owner_display_name":"ELDRED KARY","owner_url":"/insider/0001543425","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":6.0999,"price_display":"6.10","price_state":"stated","total_value":12199.8,"total_display":"12,199.80","total_whole":"12,200","shares_owned_after":41382.0,"shares_owned_after_display":"41,382","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-09-25","filed_date":"2018-09-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":14,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001133416","name":"GALECTIN THERAPEUTICS INC","url":"/issuer/0001133416","role":"Director","n_filings":14,"first_seen":"2018-09-26","last_seen":"2026-02-09"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001543425","retrieved_at":"2026-08-26T02:41:35+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}